What is the current Thrombin Market size?

The Thrombin Market is projected to register a CAGR of 4.30% during the forecast period (2024-2029) Read More

Who are the key players in Thrombin Market?

Pfizer Inc., Johnson & Johnson, Baxter, Shanghai RAAS blood products co., Ltd and General Electric Company (GE Healthcare) are the major companies operating in the Thrombin Market. Read More

Which is the fastest growing region in Thrombin Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Thrombin Market?

In 2024, the North America accounts for the largest market share in Thrombin Market. Read More

What years does this Thrombin Market cover?

The report covers the Thrombin Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Thrombin Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Thrombin Market Share

Statistics for the 2023 & 2024 Thrombin market share, created by Mordor Intelligence™ Industry Reports. Thrombin share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Thrombin Industry

The market for thrombin is moderately competitive and is currently dominated by several major players. Some of the companies that are leading the market include Pfizer Inc., Johnson & Johnson Services Inc., Mallinckrodt Pharmaceuticals, Shanghai RAAS Blood Products Co., Ltd, Japan Blood Products Organization, Mochida Pharmaceutical Co., Ltd., Octapharma, Bayer, Baxter, and General Electric Company (GE Healthcare).